evans blue has been researched along with Heart Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beauloye, C; Bertrand, L; Bouleti, C; Castanares-Zapatero, D; Communi, D; Foretz, M; Gerber, B; Germain, S; Horckmans, M; Horman, S; Laterre, PF; Lecut, C; Mathivet, T; Oury, C; Sommereyns, C; Vanoverschelde, JL; Viollet, B | 1 |
| BICAL, R; BOUCHARD, F | 1 |
| CLAY, RC; ELLIOTT, SR; SCOTT, HW | 1 |
3 other study(ies) available for evans blue and Heart Diseases
| Article | Year |
|---|---|
Connection between cardiac vascular permeability, myocardial edema, and inflammation during sepsis: role of the α1AMP-activated protein kinase isoform.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Capillary Permeability; Cells, Cultured; Coloring Agents; Cytokines; Echocardiography; Edema; Endothelial Cells; Endotoxemia; Evans Blue; Gene Silencing; Heart Diseases; Heart Ventricles; Humans; Inflammation; Lipopolysaccharides; Lung; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peroxidase; Ribonucleosides; Tight Junctions | 2013 |
[Our experience with dilution curve of Evans blue in cardiac diseases].
Topics: Diagnostic Techniques, Cardiovascular; Evans Blue; Heart Diseases; Humans; Indicator Dilution Techniques | 1960 |
Blood volume in congenital cyanotic heart disease: simultaneous measurements with Evans blue and radioactive phosphorus.
Topics: Blood; Blood Volume; Evans Blue; Heart Defects, Congenital; Heart Diseases; Humans; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary | 1951 |